Metraipolis › archive › dc_aff04eecbac7

Safety Profiles of Polymyxins, Aminoglycosides, and Imipenem/Cilastatin/Relebactam (IMI/REL) in the Treatment of Gram-Negative Infections: A Literature Review — Europe PMC PMID:42192644

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42192644
DOI: 10.3390/antibiotics15050422
License (as archived): solo-consultazione
Archived: 2026-11-03T07:44:24.332Z
SHA-256 of the archived text: c1fb7f3b32c4915322f5ac44f566908cdf56a42d4202342d8df3d49550166ae6
Stable URL of this page: https://metraipolis.com/documento/dc_aff04eecbac7

How to cite

Safety Profiles of Polymyxins, Aminoglycosides, and Imipenem/Cilastatin/Relebactam (IMI/REL) in the Treatment of Gram-Negative Infections: A Literature Review — Europe PMC PMID:42192644 — Europe PMC (en), https://europepmc.org/article/MED/42192644 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aff04eecbac7 (Metraipolis archive dc_aff04eecbac7, sha256 c1fb7f3b32c4915322f5ac44f566908cdf56a42d4202342d8df3d49550166ae6)

BibTeX

@misc{dcaff04eecbac7,
  title = {Safety Profiles of Polymyxins, Aminoglycosides, and Imipenem/Cilastatin/Relebactam (IMI/REL) in the Treatment of Gram-Negative Infections: A Literature Review — Europe PMC PMID:42192644},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42192644},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aff04eecbac7; sha256 c1fb7f3b32c4915322f5ac44f566908cdf56a42d4202342d8df3d49550166ae6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42192644. Agents can read the archived copy with the MCP tool read_document.